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Chronic taurine treatment ameliorates reduction in saline-induced the levels of organic osmolytes, such as taurine, and inor-
diuresis and natriuresis. ganic osmolytes, such as sodium, in order to re-establish
Background. Taurine is an osmolyte found in high concen-
osmotic homeostasis [5]. Third, cellular taurine depletiontration in the kidney. Both the modulation of tissue taurine
alters body fluid and electrolyte homeostasis, a mecha-stores and the exogenous administration of taurine are known
to affect renal function. Therefore, it is likely that taurine therapy nism involving, among other factors, the regulation of
could benefit the dysfunctional kidney. renal excretory function by arginine vasopressin [9, 10].
Methods. To test this idea, the present study examined the
There is a growing body of evidence indicating thateffect of chronic taurine administration on the excretory re-
taurine supplementation augments renal excretory func-sponses to acute saline volume loading by the unilaterally ne-
phrectomized (UNX) control and the UNX glucose-intolerant tion [11–13]. Although the mechanism underlying tau-
rat (ages 3 to 9 months). rine-induced natriuresis and diuresis remains elusive,
Results. Sham-operated animals excreted similar amounts of
one likely taurine-linked factor is the renal kinin-kalli-the administered fluid and sodium loads with age. However, uni-
krein system [13, 14]. Another plausible explanation forlateral nephrectomy was associated with a significant reduction
in the response to saline volume loading. This defect was promi- the regulation of renal function by taurine relies on the
nent at a younger age (that is, 3 months) in the UNX glucose transport of taurine via the renal taurine cotransporter,
intolerant than the UNX control (6 months old) rat. Chronic
a process involving the transport of taurine with a stoichi-taurine treatment ameliorated the reduction in saline-induced
ometry of 2 to 3 Na:1 Cl:1 taurine [6–8]. To ensure bodydiuresis and natriuresis by both the UNX control and the UNX
glucose intolerant rat. Both an increase in glomerular filtration taurine homeostasis, the taurine cotransporter is very
and a reduction in tubular reabsorption of fluid and sodium tightly regulated. During periods of dietary taurine ex-
caused this taurine-mediated improvement in renal excretory
cess, the activity of the renal taurine cotransporter isfunction.
down-regulated [6, 15], causing the appearance of largeConclusion. Taurine treatment protects the kidney of the UNX
rat against an age-dependent decline in excretory efficiency. amounts of taurine in the urine [10]. Since less taurine
is taken up when cotransporter activity is reduced, it fol-
lows that less sodium is also transported into the cell. Thus,
Taurine (2-aminoethanesulfonic acid) is an amino acid it is plausible that taurine supplementation could lead to
found in high concentration in mammalian cells. Among taurinuria with attendant sodium and fluid excretion.
its putative physiological roles in the kidney is the regula- Based on the direct and indirect effects of taurine on
tion of ion transport and osmotic balance, with the regu- renal excretory function, our study tested the hypothesis
lation of ion transport being particularly important [1–5]. that chronic taurine supplementation preserves renal
Several mechanisms are involved in the regulation of function under conditions of reduced diuresis and natri-
ion transport by taurine. First, taurine transport per se is uresis. Recently, we found that the removal of one kid-
directly coupled to sodium and chloride flux [5–8]. Sec- ney early in life (that is, 4 weeks of age) led to a reduction
ond, during periods of osmotic stress, the cell modulates in saline volume-induced diuresis and natriuresis of the
control and glucose intolerant rats as the animals aged
[16, 17]. This deficit was particularly apparent followingKey words: glucose intolerance, uninephrectomy, excretion and age,
ion transport, taurinuria. acute plasma volume expansion (such as, infusion of a
saline volume load), a maneuver that requires an imme-
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diuresis and natriuresis by the uninephrectomized con- three groups of rats for each condition at each age. At
trol and glucose-intolerant rats (ages 3 to 9 months). about 3, 6 and 9 months of age, each rat was placed in-
dividually in metabolic cages and 24-hour urine samples
collected for determination of daily protein excretion [22].METHODS
To prepare for the renal function studies in the con-
Wistar-Kyoto (WKY) rats, obtained from Harlan Lab- scious animal, each rat was instrumented with femoral
oratories (Indianapolis, IN, USA), were bred at the Med- vessels cannuli and a stainless steel bladder catheter, with
ical College of Georgia animal facility. To produce the all procedures performed under ether anesthesia [9, 10,
model of glucose intolerance, two-day-old male rats were 12, 16, 17]. Two days after surgery, each rat was placed
injected intraperitoneally with 90 mg/kg of streptozo- in an environmental conditioning unit (Braintree, Brain-
tocin [17, 19–21]; control littermates received an injection tree, MA, USA); all rats were conditioned to the units
of citrate buffer (0.1 mol/L, pH 4.5). It is noteworthy that for three hours per day for seven days prior to adminis-
injection of streptozotocin into an adult rat produces an tering the test. After the arterial and venous catheters
insulinopenic condition that resembles type 1 diabetes were flushed with 0.2 mL of isotonic saline containing 5
[22, 18], while injection of streptozotocin into the neo- U/mL of heparin, the recording of hemodynamic param-
nate rat results in impaired insulin secretion and action
eters was initiated (Blood Pressure Analyzer; Micro-
[19, 20]. During the early stages of the disease, basal
Med, Louisville, KY, USA).plasma glucose and insulin are similar between the con-
To determine the glomerular filtration rate (GFR),trol and the neonatal streptozotocin-treated rats [20, 21].
each rat received an intravenous injection of 0.2 mL ofHowever, in accordance with the development of insulin
isotonic saline containing a priming dose of 2 Ci ofresistance and impaired glucose tolerance, the neonatal 3H-inulin (Dupont Co., Boston, MA, USA), followedstreptozotocin-treated rats display a significantly greater
immediately by a 20 L/min intravenous infusion of iso-elevation in plasma glucose and insulin levels after a glu-
tonic saline containing 2.5 Ci/mL of 3H-inulin [10, 16,cose challenge than the control rats [20, 21]. With in-
17]. After a 45-minute equilibration period, which is suf-creasing age, an elevation in fasting plasma glucose level
ficient to achieve a steady state radioactive level in thedevelops (Results section), heralding the onset of type
plasma, a 30-minute urine sample was collected for deter-2 diabetes [23]. The neonatal streptozotocin-treated rat
mination of baseline excretory parameters. A 30-minuteis neither obese nor hypertensive, thereby providing a
volume expansion (equivalent to 5% of the animal’s bodyunique opportunity to examine the effect of glucose in-
wt) was then initiated with isotonic saline containingtolerance/type 2 diabetes per se on organ function. The
3H-inulin [16, 17]. This was followed by infusion of iso-animals were weaned at 21 days of age and were main-
tonic saline containing 3H-inulin at the rate of 20 L/tained at constant humidity (60  5%), temperature
min for the remainder of the experiment. Urine samples(24  1C) and light cycle (0600 to 1800 hours). Unless
were collected at 15, 30, 60, and 90 minutes after initia-otherwise specified, the animals had free access to food
tion of the saline volume load. At the midpoint of eachand drinking fluid.
urinary collection period, 0.2 mL of arterial blood sampleAt four weeks of age, the streptozotocin-injected and
was collected for determination of plasma radioactivitythe control rats underwent either sham operation or uni-
and electrolyte composition; the blood sample was re-lateral nephrectomy (UNX) with the procedure per-
placed with an equal volume of isotonic saline. At theformed under ether anesthesia [16, 17, 22]. Following a
conclusion of renal function studies the animals wereperiod of two weeks for compensatory renal hypertrophy
sacrificed with pentobarbital (50 mg/kg; IV); kidneyto occur, impaired glucose tolerance was confirmed by
weight was determined for each animal.the administration of a glucose tolerance test. The test
Sodium (Na) and K were measured by flame pho-was repeated at about 3, 6 and 9 months of age, each
tometry and used to calculate the sodium and potassiumtime just prior to initiating the renal function studies. In
excretion rates. GFR and fractional excretion of fluidthe glucose tolerance test, time 0 (that is, fasting) blood
(FEH2O) and sodium (FENa) were calculated by usingsamples were obtained after an overnight fast. The ani-
standard clearance formulas [10, 16]. Plasma taurine con-mals were then subjected to a glucose challenge (2 g/kg
centration and the rate of daily taurine excretion wereIP) and blood samples were taken at two-hours post-
determined as described previously [10].injection for glucose analyses [17, 21]. Following con-
firmation of glucose intolerance in the streptozotocin-
Statisticsinjected rats, the UNX rats were further subdivided
All data were statistically analyzed by the analysis ofand were either maintained on tap water (UNX-vehicle)
variance (ANOVA; significance criteria of P 0.05) withor were given water containing 1% taurine (UNX-tau-
Duncan’s test used for comparison of the mean values.rine); the sham-operated rats were maintained on tap
water (sham-vehicle). Therefore, the protocol yielded All data are reported as means  SEM.
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Table 1. Several features of the experimental groups




Group months N mg/g Fasting post-glucose
Control
Sham 3 9 27711 2.20.0 7.80.2 842 923
6 5 37116 2.80.0 7.70.3 823 1325
9 6 4356 3.10.1 7.00.1 934 15918
UNX 3 7 2947 1.60.0 5.40.1 832 992
6 5 40112 1.90.1 4.90.1 962 1005
9 8 4695 2.50.0 5.40.1 862 1406
UNX/taurine 3 7 28511 1.80.1 6.30.4b 873 1084
6 8 3546d 2.30.1 6.50.3b 933 13310
9 8 42610d 2.00.1 4.80.1 883 1369
Glucose intolerant
Sham 3 6 25516 1.80.1 7.20.3 812 15013a
6 5 35917 2.60.2 7.20.3 924 18723a
9 6 4064a 2.80.1 6.90.3 1218ac 25626a
UNX 3 7 26411 1.60.1 5.90.1 852 16412a
6 8 3498 1.90.0 5.30.1 984 22416a
9 6 39312a 2.20.1 5.50.3 1075ac 20323a
UNX/taurine 3 7 23011 1.50.1 6.80.3b 733 20616a
6 8 3579 2.00.0 5.60.1 1015 28323a
9 6 40010 2.00.1 5.10.2 1194ac 2768a
a P  0.05 compared to their control counterparts
b P  0.05 compared to their vehicle-treated counterparts
c P  0.05 compared to their 3-month-old counterparts
d P  0.05 compared to age-matched UNX control groups
RESULTS lower in the UNX rats than in the sham-operated groups
(P 0.05; Table 1). The remaining kidney of the 9-month-Fasting blood glucose concentration was similar in the
old UNX rat displayed a 54% increase in size relative to3- and 6-month-old glucose intolerant animals. However,
one of the two kidneys of the 9-month-old sham-oper-the 9-month-old glucose intolerant groups manifested a
ated rat. Uninephrectomy also led to renal hypertrophyhigher fasting blood glucose concentration compared to
of the remaining kidney in the 3-month-old and 6-month-their 3-month-old counterparts or their age-matched
old UNX animals, although the increase in kidney sizecontrol counterparts (P  0.05; Table 1). As expected,
was somewhat less than the older UNX rat (38% andthe intraperitoneal administration of a glucose load sig-
27% in 3- and 6-month-old animals, respectively). The cor-nificantly increased blood glucose concentration in all
responding values for the 3-month, 6-month and 9-month-groups. However, two hours after administration of the
old glucose intolerant rats were 64%, 47%, and 59%,
glucose load, the blood glucose concentration of the
respectively. Comparison of the glucose intolerant and
three glucose intolerant groups remained significantly control rats revealed that the younger glucose intolerant
higher than the levels found in the control groups (P  rats displayed a greater increase in kidney size in response
0.05; Table 1). An elevation in fasting blood glucose to uninephrectomy than their control counterparts. Tau-
level in association with impaired glucose tolerance is rine treatment increased the kidney size of the 3- and
suggestive of type 2 diabetes [23]. While fasting blood 6-month-old UNX control rats and the 3-month-old
glucose level was greater in the older streptozotocin- UNX glucose intolerant rats compared to their vehicle-
injected rats, impaired glucose tolerance was a feature treated counterparts (Table 1).
of all streptozotocin-treated rats. Therefore, all strepto- Unilateral nephrectomy and taurine treatment had no
zotocin-injected rats are referred to as glucose intolerant significant effect on mean arterial pressure (range 122
rats throughout this article. to 133 mm Hg, data not shown). However, taurine treat-
The uninephrectomized control rats generally displayed ment was associated with a reduction of 40 to 50 beats/
similar body weights compared to their age matched sham min in heart rate in both the 3- and 6-month-old UNX
counterparts. However, taurine treatment slightly reduced control and the UNX glucose intolerant rats (P  0.05;
the body weight of the 6- and 9-month-old UNX control heart rate data not shown). Consistent with previous
rats, although not that of the glucose intolerant rats (Ta- reports [16–18], the administration of an isotonic saline
ble 1). As expected, total kidney weight (KW) and kid- load did not significantly affect either the mean arterial
pressure or the heart rate of any group (data not shown).ney size (KW normalized relative to body weight) were
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Fig. 1. Effects of chronic taurine treatment on isotonic saline-stimulated diuresis and natriuresis by the unilaterally nephrectomized (UNX) control
rat (ages 3 to 9 months). (A and B) Diuretic and natriuretic responses to a saline challenge, expressed as the percent of the administered fluid and
sodium loads that are excreted within 90 minutes of the saline load. (C and D) Excretion data normalized relative to kidney weight. Symbols are:
() sham operated; ( ) UNX; ( ) UNX/taurine; *P 0.05 compared to 3-month-old UNX group and their age-matched UNX-taurine counterparts;
**P  0.05 compared to 9-month-old sham-operated group; #P  0.05 compared to their age-matched UNX counterpart.
It has been well documented that unilateral nephrec- intolerant) illustrate the percent of an administered fluid
and sodium load that were excreted 90 minutes aftertomy is associated with a compensatory increase in fluid
and sodium excretion by the remaining kidney [24–26]. the initiation of the saline infusion while Figure 1 C, D
(control) and Figure 2 C, D (glucose intolerant) showThis was reflected in the higher baseline rates of fluid
and sodium excretion, normalized relative to KW, of the the same data after normalization relative to kidney
weight. As expected, the administration of a saline vol-UNX control rats compared to their age-matched sham-
operated counterparts (P 0.05; data not shown). How- ume load significantly increased fluid and sodium excre-
tion in all of the groups. Aging alone had no effect onever, a similar phenomenon does not occur in the glucose
intolerant rats, as the baseline rates of fluid and sodium the absolute percentages of fluid and sodium that were
excreted by the sham-operated control rats (Fig. 1 A, B).excretion were similar in the UNX and sham-operated
groups. While taurine treatment reduced the baseline However, the 9-month-old control animal showed a re-
duction in renal excretory efficiency relative to therate of fluid, but not sodium, excretion in the 3- and
6-month-old UNX control groups, it had no apparent 6-month-old sham operated animal, as evidenced by the
decline in natriuresis (P  0.05) and diuresis in the kid-effect on the excretion profile of the UNX glucose intol-
erant animals (data not shown). ney weight normalized data (Fig. 1 C, D). Uninephrec-
tomy appeared to accelerate the loss of excretory effi-Figure 1 A, B (control) and Figure 2 A, B (glucose
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Fig. 2. Effects of chronic taurine treatment on saline-stimulated diuresis and natriuresis by unilaterally nephrectomized (UNX) glucose intolerant
rats. (A and B) Diuretic and natriuretic responses to a saline load, expressed as the percent of the administered fluid and sodium loads that are
excreted within 90 minutes of the saline load. (C and D) Excretion data normalized relative to kidney weight. Symbols are: () sham operated; ( )
UNX; ( ) UNX/taurine; *P  0.05 compared to their age-matched sham or UNX-taurine counterparts; **P  0.05 compared to 9-month-old UNX
group; #P  0.05 compared to the 3-month-old sham group.
ciency. In fact, a significant reduction in both the absolute administered fluid and sodium loads that were excreted
by the glucose intolerant sham-operated rats within 90and normalized percentages of fluid and sodium excre-
tion data were observed in the 6- and 9-month-old UNX minutes of the challenge (Fig. 2 A, B). Nonetheless, the
6-month-old glucose intolerant rat showed a decrease incontrol rat relative to their 3-month-old counterpart,
suggesting an age-dependent propensity toward fluid and excretory efficiency relative to the 3-month-old glucose
intolerant rat (Fig. 2 C, D). Unilateral nephrectomy re-sodium retention (Figs. 1A–D). Interestingly, at 3 and
6 months of age, the taurine-treated UNX control rat sulted in a significant reduction in saline-induced diuresis
and natriuresis of the glucose intolerant rat, suggestingmanifested saline-induced diuretic and natriuretic re-
sponses comparable to those displayed by their age- a propensity toward sodium and fluid retention by the
UNX animals (Fig. 2). However, the differential in excre-matched sham-operated control counterparts (Fig. 1).
The beneficial effect of taurine treatment was more tion between the sham-operated glucose intolerant and
UNX glucose intolerant groups was less apparent in theprominent in the 9-month-old UNX control rat, as fluid
and sodium excretion in this group, when normalized 6- and 9-month-old rats, particularly when the data were
normalized relative to kidney weight. This occurred be-relative to kidney weight, significantly exceeded these
values in the 9-month-old sham-operated control group cause the excretory efficiency was reduced in the 6- and
9-month-old sham-operated glucose intolerant rats com-(Figs. 1 C, D).
Age had no effect on the absolute percentage of the pared to their 3-month-old counterparts (Fig. 2 C, D).
Mozaffari and Schaffer: Chronic taurine therapy 1755
Taurine treatment significantly improved saline-stimu- cant proteinuria compared to their sham-operated coun-
terparts (UNX, 69.7  4.9 vs. sham, 26.6  1.0 mg/day).lated diuresis and natriuresis of the UNX glucose intoler-
ant rat, with the effect being more prominent in the Taurine treatment reduced daily protein excretion in the
UNX rats to 50.5  2.1 mg/day (P  0.05). By compari-3-and 6-month-old groups (Fig. 2).
A decline in excretory function is generally caused by son, the UNX glucose-intolerant rats excreted more pro-
tein than their sham-operated counterparts by 6 monthseither a decrease in the glomerular filtration rate (GFR)
or in the fractional excretion of the filtered sodium and of age, an effect that was reversed by taurine treatment
(UNX, 72.9  8.0; sham, 47.2  6.6; and UNX/taurine,fluid loads. Therefore, to examine the basis underlying the
loss of excretory function of the UNX animals, the GFR 44.7  4.6 mg/day).
The plasma taurine concentrations were similar be-and fractional excretion of fluid and sodium were mea-
sured before and following a saline-volume load. As ex- tween 9-month-old UNX control and UNX glucose intol-
erant rats (0.35  0.09 vs. 0.38  0.07 mol/mL), butpected, saline loading was accompanied by an elevation
in the GFR in all of the animal groups (Fig. 3; 6-month- were lower than their counterparts treated with taurine
(0.78  0.06 vs. 0.66  0.06 mol/mL; P  0.05). Simi-old rats). However, the rise in GFR following the saline
load was greater for both the UNX control and UNX larly, daily taurine excretion was significantly (P  0.05)
higher in the 9-month-old taurine-treated control andglucose intolerant rats that were treated with taurine
compared to their vehicle-treated counterparts. Indeed, glucose-intolerant rats (617.4  35.9 vs. 782.6  34.4
mol/day, respectively) than in their age-matched coun-the GFR of the taurine-treated UNX animals was even
greater than that of the sham-operated groups (Fig. 3 terparts that consumed tap water (118.5  8.0 vs. 143 
3.3 mol/day).A, D). Among the UNX control rats, the major defect
appeared to be a reduction in the fractional excretion
of fluid and sodium (Fig. 3, B, C). Significantly, taurine
DISCUSSION
treatment restored the fractional excretion of both fluid
The present study demonstrates that chronic oral tau-and sodium in these animals to nearly the levels seen in
rine supplementation ameliorates the age-related declinethe sham-operated group (Fig. 3, B, C). Although the
in saline volume-induced diuresis and natriuresis by theeffect was less dramatic, taurine treatment also increased
UNX control and UNX glucose intolerant rat. These find-the fractional excretion of fluid and sodium in the UNX
ings corroborate our earlier report that taurine depletionglucose intolerant group (Fig. 3 E, F). Moreover, while
in rat reduces the initial rate of saline volume-inducedreduced tubular reabsorption is the primary contributor
diuresis and natriuresis and that acute taurine adminis-to the enhanced saline-induced diuresis and natriuresis
tration augments these responses in the normal rat [12].in the taurine-treated, 3-month-old UNX glucose intoler-
Both a potentiation in the glomerular filtration rate andant rat, the effect of taurine treatment on renal fluid and
a reduction in tubular reabsorption of fluid and sodiumsodium excretion of the 9-month-old UNX control and
cause this taurine-induced improvement in the responseglucose-intolerant rat is related to both augmented sa-
to saline volume loading. These renal effects are evidentline-induced rise in GFR and a reduction in tubular reab-
at a time when proteinuria is not a prominent feature (thatsorption (data not shown).
is, 6 and 3 months of age in control and glucose intolerantConsistent with other reports [24, 26, 27], unilateral
rats, respectively), suggesting that the effect of taurinenephrectomy was associated with a significant elevation
may involve modulation of renal function by neurohu-in the baseline rate of potassium excretion in all of the
moral regulators.control rats (99%, 70% and 49% in 3-, 6- and 9-month-
Consistent with our previous observation [16, 17], Fig-old rats; respectively), as well as the 3-month-old glu-
ures 1 and 2 reveal that saline-induced diuresis and natri-cose-intolerant rats (63%). Taurine treatment gener-
uresis by the UNX rat declines with age. Interestingly,ally reduced the baseline rate of potassium excretion,
this impairment was prominent earlier in the UNX glu-leading to normalization in the excretion rate. In the
cose intolerant rat than in the UNX control rat (3 vs. 63-month-old UNX control group, total potassium excre-
months of age, respectively). Since aging is known totion, defined as the excretion that occurred within 90
reduce renal reserve capacity [28], it is likely that theminutes of administration of the saline volume load,
observed reduction in saline-induced diuresis and natri-was significantly greater than their age-matched sham-
uresis reflects an impairment in the response of the agingoperated counterparts; taurine treatment normalized po-
kidney to the volume challenge, an effect that apparentlytassium excretion in the control UNX rat (sham, 126.1
is accelerated by impaired glucose tolerance. Since the7.7; UNX, 220.3  6.8; UNX/taurine, 128.6  12 Eq/g
kidney’s response to saline volume loading is regulatedKW). However, taurine treatment had no significant ef-
in part by neuronal and humoral factors released duringfect on the total amount of potassium excreted by the
the volume challenge [18], it is possible that the releaseglucose intolerant rats.
The 9-month-old UNX control rat manifested signifi- of these factors is adversely affected in the older UNX
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Fig. 3. Glomerular filtration rate (GFR), fractional excretion of fluid and sodium by sham-operated (), unilaterally nephrectomized (UNX; ) and
taurine treated UNX () rats. (A–C ) Six-month-old control rat data. (D–F) Six-month-old glucose intolerant rat data. *P  0.05 compared to the
UNX/taurine group at the same time point.
animals. However, this seems unlikely because the older study commonly has been utilized to examine the effect
of reduced nephron mass on both remnant kidney func-sham-operated rat responds normally to the saline load.
Rather, the data suggest that a chronic reduction in renal tion and the ability of therapeutic modalities to preserve
remnant kidney function. Most investigations of remnantmass is associated with a defective responsiveness of
the remaining nephrons to the released neuronal and kidney function have explored renal adaptation to either
subtotal nephrectomy (that is, 5/6) or unilateral nephrec-humoral factors.
The reduced renal mass model used in the present tomy [24–27, 29–31]. While subtotal nephrectomy is of-
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ten associated with the development of systemic hyper- As illustrated in Figure 3, a combination of augmented
glomerular function and reduced tubular reabsorptiontension [29–31], uninephrectomy leads to hypertension
when combined with other maneuvers (that is, deoxycor- activity contribute to this beneficial effect of taurine. The
reasons for the beneficial effect of taurine therapy areticosterone acetate-salt or high salt diet) [16, 22]. There-
fore, to avoid the complication of systemic hypertension, not known but the following aspects are noteworthy.
First, taurine exerts sympatholytic effects [33–34], whichuninephrectomy was used in the present study.
In agreement with previous studies [24–26], we found should be capable of increasing sodium excretion. There-
fore, chronic taurine therapy could attenuate adrenergic-that the baseline rates of fluid and sodium excretion by
the young UNX rat were elevated in the remaining kid- mediated sodium retention, culminating in greater excre-
tion. However, this scenario seems unlikely since reflexney (data not shown). However, as the animal ages, a
defect develops in the renal response to acute plasma withdrawal of renal sympathetic nerve activity is an im-
portant contributor to saline volume-induced diuresisvolume expansion. A similar defect has been observed
in the streptozotocin-treated type 1 diabetic rat that man- and natriuresis [18]. Second, taurine antagonizes several
actions of angiotensin II [35]. Yet, the relevance of theifests marked impairment in acute saline volume-induced
diuresis and natriuresis [18]. The impaired response to taurine-angiotensin II interaction with respect to renal
function remains to be established. Third, taurine pro-volume loading in the type 1 diabetic rat appears to be
partially associated with reduced responsiveness to atrial motes diuresis and natriuresis and the activation of the
renal kallikrein system [11–14], and the latter could con-natriuretic peptide, a regulatory factor released during
volume expansion to enhance diuresis and natriuresis tribute to renal fluid and sodium excretion during volume
expansion. Clearly, the relevance of the renal kallikrein[18]. Based on the similarities between the aging UNX
rat and the type 1 diabetic rat in renal responses to system to the observed responses to taurine warrants
further investigation. Fourth, aging is associated with anplasma volume expansion, it would be attractive to sug-
gest that long-term uninephrectomy also leads to im- attenuation of the pressure-diuresis-natriuresis relation-
ship [36], an effect that is likely accelerated with unilat-paired responsiveness to atrial natriuretic peptide. None-
theless, the response to volume loading is complex and eral nephrectomy. Our data showed that one of the arms
of this relationship, namely blood pressure, was not af-involves several components including: (a) the afferent
limb (that is, volume receptors, electromechanical cou- fected by age, uninephrectomy or taurine treatment.
Therefore, it is likely that a blunting of the relationshippling and afferent fibers); (b) the central sites for neu-
ronal processing of afferent input; and (c) the efferent contributed to the reduced renal responses of the UNX
rats. Presumably, taurine treatment ameliorates this defi-limb (that is, release and/or action of humoral factors
and renal sympathetic nerve activity [18]). Modulation cit. Finally, atrial natriuretic peptide release contributes
to saline volume-induced diuresis and natriuresis [18].of any of these components would account for the obser-
vations with the aging UNX rat. Since atrial extracts from taurine-treated hamsters cause
greater diuresis and natriuresis than those obtained fromOne of the important findings of this study is that
taurine therapy ameliorates the age-related decline in their vehicle-treated counterparts [37], it is likely that
taurine promotes the release of atrial natriuretic peptide.saline volume-induced diuresis and natriuresis by the
UNX control and UNX glucose intolerant rat. The tau- It remains to be determined if taurine can potentiate the
effects of atrial natriuretic peptide in the UNX rat also.rine-induced improvement in renal fluid and sodium ex-
cretions in this and previous studies [11–13], is in appar- Aside from the putative renal effects of taurine me-
diated by the regulatory neural and humoral factors,ent contrast to the findings of McBroom and Davidson,
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